{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P18621",
      "entity_text" : "PD-1",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0568" ],
      "CellType" : [ "cl:CL:0000623" ],
      "Species" : [ "taxonomy:10090" ]
    }
  },
  "verbose_text" : "In this study, we have demonstrated that, as opposed to conventional continuous MEKi treatment used in the clinic, a pulsatile schedule of MEKi treatment is more effective at controlling tumor progression and enhancing T cell activation with increased levels of CTLA-4 and PD-1 expression.",
  "reading_complete" : "2020-08-08T10:51:41Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T10:49:20Z",
  "trigger" : "levels",
  "evidence" : [ "levels of CTLA-4 and PD-1" ],
  "pmc_id" : "6719696",
  "score" : 0
}